Celina Ang, MD
- ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology
Specialties:Oncology (Cancer), Hematology-Oncology
I am a medical oncologist who specializes in the care of patients with gastrointestinal malignancies. My research interests focus on the investigation of new therapies for these diseases, particularly cancers of the liver and biliary system.
American Board of Internal Medicine
- Gastrointestinal Cancers
- Liver Cancer
MD, University of Western Ontario
BSc, McGill University
Residency, Internal Medicine, Montreal General Hospital
Fellowship, Oncology, McGill University
Fellowship, Gastrointestinal Oncology, Memorial Sloan-Kettering Cancer Center
Clinical training and research grant
Montreal General Hospital Foundation Research Award
Dr. L. DeWitt Wilcox Award in Medical Research
James McGill Entrance Scholarship
- A Phase Ib Dose Escalation Study of OMP-54F28 in Combination with Sorafenib in Patients with Hepatocellular Carcinoma
The purpose of this study is to test the safety of an experimental drug, OMP-54F28, when combined with sorafenib that is standard treatme...
- A phase II/III trial of neoadjuvant FOLFOX, with selective use of combined modality chemoradiation versus preoperative combined modality chemoradiation for locally advanced rectal cancer patients undergoing low anterior resection with total mesorectal excision
The standard treatment for locally advanced rectal cancer involves chemotherapy and radiation, known as 5FUCMT, (the chemotherapy drugs 5-fluorouracil/capecitabine and radiation therapy) prior to surgery. Although radiation therapy to the pelvis has been a standard and importa...
- A phase II multicenter, single arm study of oral BGJ398 in adult patients with advanced or metastatic cholangiocarcinoma with FGFR2 gene fusions or other FGFR genetic alterations who failed or are intolerant to platinum-based chemotherapy
The purpose of this study is to find out if the drug BGJ398 is safe and has beneficial effects in people who have advanced cholangiocarcinoma. BGJ398 is a medicine which has not been approved by U.S. Food and Drug Administration (FDA) for the treatment of people with you...
- A pilot feasibility study of high dose vitamin D replenishment in patients with resected early stage colon carcinoma
The purpose of this study is to determine whether giving high doses of vitamin D can increase the body's vitamin D stores to levels that may prevent cancer recurrence (ie return) in individuals who have had surgery for early stage colon cancer. Nearly 80% of the U.S. pop...
Ang C, Chambers AF, Tuck AB, Winquist E, Izawa JI. Plasma osteopontin levels are predictive of disease stage in patients with transitional cell carcinoma of the bladder. BJU international 2005 Nov; 51(6).
Ang C, Guiot MC, Ramanakumar AV, Roberge D, Kavan P. Clinical significance of molecular biomarkers in glioblastoma.. Can J Neurol Sci 2005 Oct; 37(5): 625-30.
Ang C, Hauerstock D, Guiot MC, Kasymjanova G, Roberge D, Kavan P, Muanza T. Characteristics and outcomes of medulloblastoma in adults. Pediatric blood & cancer 2008 Feb; 51(5).
Ang C, Kornbluth M, Thirlwell M, Rajan R. Capecitabine-induced cardiotoxicity: case report and review of the literature. Current oncology (Toronto, Ont.) 2010 Sep; 17(1).
Cohen V, Agulnik J, Ang C, Kasymjanova G, Batist G, Small D, Brandao G, Chong G, Miller WH. Epidermal growth factor receptor mutations detected by denaturing high-performance liquid chromatography in nonsmall cell lung cancer: impact on response to therapy with epidermal growth factor receptor-tyrosine kinase inhibitors. Can J Neurol Sci 2010 Sep; 37(18).
Ang C, O'Reilly EM, Abou-Alfa GK, Shamseddine A, Skouri H, Tawil A, Eloubeidi MA, Lowery M, Kharfan-Dabaja M, Kaprealian T, Temraz S, Sibai H, Farran H, Shah MA. Gastrointestinal cancer educational case series: management of metastatatic adenocarcinoma of unknown primary origin in a Ph+ ALL survivor.. J Gastrointest Cancer 2011 Sep; 42(3): 165-70.
Postow M, Shah MA, Lowery M, Shamseddine A, El-Kutoubi A, Al Olayan A, Naghy M, Ang C, Tamraz S, Jazieh AR, O'Reilly EM, Kelsen DP, Abou-Alfa GK. A man with Klinefelter's syndrome and new abdominal distension: a discussion of evaluation and management. Journal of gastrointestinal cancer 2012 Jun; 43(2).
Ang C, O'Reilly EM, Abou-Alfa GK. MicroRNA, hypoxic stress and hepatocellular carcinoma: future directions [editorial]. J Gastroenterol Hepatol 2011 Nov; 26(11): 1686-8.
Ang C, Janjigian YY, Shamseddine A, Tawil A, Lowery MA, Intlekofer A, Faraj W, Al-Olayan A, Tang L, O'Reilly EM, Geara F, Al-Kutoubi A, Kelsen DP, Abou-Alfa GK. A case of advanced gastric cancer. Gastrointestinal cancer research : GCR 2012 Mar; 5(2).
Ang C, O'Reilly EM, Abou-Alfa GK. Targeted agents and systemic therapy in hepatocellular carcinoma. Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2013; 190.
Abou-Alfa GK, Ang C. Dx/Rx Liver Cancer 1st Edition. Burlington, MA, Jones & Bartlett Learning;.
Ang C, Abu-Alfa AK, Abdullah K, Lowery M, Sibai H, El Farran H, Tamraz S, Al Olayan A, Shamseddine A, Naghy M, Faraj W, O'Reilly EM, Abou-Alfa GK. Hepatocellular carcinoma following renal transplantation. Gastrointestinal cancer research : GCR 2011 Sep; 4(5-6).